Whole genome sequencing snapshot of multi-drug resistant Klebsiella pneumoniae strains from hospitals and receiving wastewater treatment plants in Southern Romania.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 23 08 2019
accepted: 07 01 2020
entrez: 31 1 2020
pubmed: 31 1 2020
medline: 15 4 2020
Statut: epublish

Résumé

We report on the genomic characterization of 47 multi-drug resistant, carbapenem resistant and ESBL-producing K. pneumoniae isolates from the influent (I) and effluent (E) of three wastewater treatment plants (WWTPs) and from Romanian hospital units which are discharging the wastewater in the sampled WWTPs. The K. pneumoniae whole genome sequences were analyzed for antibiotic resistance genes (ARGs), virulence genes and sequence types (STs) in order to compare their distribution in C, I and E samples. Both clinical and environmental samples harbored prevalent and widely distributed ESBL genes, i.e. blaSHV, blaOXA, blaTEM and blaCTX M. The most prevalent carbapenemase genes were blaNDM-1, blaOXA-48 and blaKPC-2. They were found in all types of isolates, while blaOXA-162, a rare blaOXA-48 variant, was found exclusively in water samples. A higher diversity of carbapenemases genes was seen in wastewater isolates. The aminoglycoside modifying enzymes (AME) genes found in all types of samples were aac(6'), ant(2'')Ia, aph(3'), aaD, aac(3) and aph(6). Quinolone resistance gene qnrS1 and the multi-drug resistance oqxA/B pump gene were found in all samples, while qnrD and qnrB were associated to aquatic isolates. The antiseptics resistance gene qacEdelta1 was found in all samples, while qacE was detected exclusively in the clinical ones. Trimethroprim-sulfamethoxazole (dfrA, sul1 and sul2), tetracyclines (tetA and tetD) and fosfomycin (fosA6, known to be located on a transpozon) resistance genes were found in all samples, while for choramphenicol and macrolides some ARGs were detected in all samples (catA1 and catB3 / mphA), while other (catA2, cmIA5 and aac(6')Ib / mphE and msrE) only in wastewater samples. The rifampin resistance genes arr2 and 3 (both carried by class I integrons) were detected only in water samples. The highly prevalent ARGs preferentially associating with aquatic versus clinical samples could ascribe potential markers for the aquatic (blaSHV-145, qacEdelta1, sul1, aadA1, aadA2) and clinical (blaOXA-1, blaSHV-106,blaTEM-150, aac(3)Iia, dfrA14, oqxA10; oqxB17,catB3, tetD) reservoirs of AR. Moreover, some ARGs (oqxA10; blaSHV-145; blaSHV-100, aac(6')Il, aph(3')VI, armA, arr2, cmlA5, blaCMY-4, mphE, msrE, oqxB13, blaOXA-10) showing decreased prevalence in influent versus effluent wastewater samples could be used as markers for the efficiency of the WWTPs in eliminating AR bacteria and ARGs. The highest number of virulence genes (75) was recorded for the I samples, while for E and C samples it was reduced to half. The most prevalent belong to three functional groups: adherence (fim genes), iron acquisition (ent, fep, fyu, irp and ybt genes) and the secretion system (omp genes). However, none of the genes associated with hypervirulent K. pneumoniae have been found. A total of 14 STs were identified. The most prevalent clones were ST101, ST219 in clinical samples and ST258, ST395 in aquatic isolates. These STs were also the most frequently associated with integrons. ST45 and ST485 were exclusively associated with I samples, ST11, ST35, ST364 with E and ST1564 with C samples. The less frequent ST17 and ST307 aquatic isolates harbored blaOXA-162, which was co-expressed in our strains with blaCTX-M-15 and blaOXA-1.

Identifiants

pubmed: 31999747
doi: 10.1371/journal.pone.0228079
pii: PONE-D-19-23806
pmc: PMC6992004
doi:

Substances chimiques

Anti-Bacterial Agents 0
Quinolones 0
Waste Water 0
beta-Lactams 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0228079

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Clin Infect Dis. 2000 Mar;30(3):473-8
pubmed: 10722430
Clin Microbiol Rev. 2016 Apr;29(2):321-47
pubmed: 26960938
Microbiol Spectr. 2016 Feb;4(1):
pubmed: 26999397
Open Forum Infect Dis. 2018 Dec 14;6(1):ofy351
pubmed: 30631796
Lancet Infect Dis. 2016 Sep;16(9):e190-e195
pubmed: 27402393
Front Microbiol. 2017 Nov 10;8:2232
pubmed: 29176971
Am J Public Health. 2011 Nov;101(11):2068-79
pubmed: 21940915
J Glob Antimicrob Resist. 2013 Dec;1(4):217-220
pubmed: 27873616
J Infect Dev Ctries. 2016 Aug 02;10(7):728-34
pubmed: 27482804
ISME J. 2015 Jun;9(6):1269-79
pubmed: 25500508
J Infect Public Health. 2018 Nov - Dec;11(6):812-816
pubmed: 29907439
Curr Issues Mol Biol. 2015;17:11-21
pubmed: 24821872
J Enzyme Inhib Med Chem. 2013 Oct;28(5):990-6
pubmed: 22845331
Front Microbiol. 2018 Feb 09;9:188
pubmed: 29479347
Int J Med Microbiol. 2013 Dec;303(8):697-700
pubmed: 24183483
mBio. 2017 Aug 29;8(4):
pubmed: 28851843
Acta Microbiol Immunol Hung. 2018 Jun 1;65(2):135-150
pubmed: 29471690
Environ Sci Pollut Res Int. 2016 Mar;23(5):4953-8
pubmed: 26782324
Sci Total Environ. 2019 Nov 15;691:80-92
pubmed: 31319261
Sci Total Environ. 2016 Apr 15;550:1103-1109
pubmed: 26871556
Antimicrob Agents Chemother. 2014 Jul;58(7):4035-41
pubmed: 24798270
Infect Genet Evol. 2018 Oct;64:219-224
pubmed: 29964191
J Antimicrob Chemother. 2016 Sep;71(9):2460-5
pubmed: 27261267
J Antimicrob Chemother. 2018 Jan 1;73(1):84-87
pubmed: 29040585
Antimicrob Agents Chemother. 2012 Apr;56(4):2125-8
pubmed: 22290940
Front Cell Infect Microbiol. 2017 Nov 21;7:483
pubmed: 29209595
PLoS One. 2017 Jun 2;12(6):e0178880
pubmed: 28575064
J Microbiol Biotechnol. 2015 Jan;25(1):137-42
pubmed: 25348695
J Glob Antimicrob Resist. 2019 Jun;17:189-194
pubmed: 30639890
Microb Drug Resist. 2014 Feb;20(1):30-8
pubmed: 23952363
Sci Total Environ. 2019 Nov 10;690:1-6
pubmed: 31299565
PLoS One. 2015 Nov 23;10(11):e0143214
pubmed: 26599338
J Antimicrob Chemother. 2014 Feb;69(2):287-91
pubmed: 24092657
Food Microbiol. 2017 May;63:58-71
pubmed: 28040182
mSphere. 2018 Sep 19;3(5):
pubmed: 30232165
Emerg Infect Dis. 2009 Oct;15(10):1648-50
pubmed: 19861064
Sci Total Environ. 2019 Apr 20;662:227-235
pubmed: 30690357
Antimicrob Agents Chemother. 2001 Oct;45(10):2971-2
pubmed: 11583008
Eur Rev Med Pharmacol Sci. 2015 May;19(10):1888-94
pubmed: 26044236
Int J Antimicrob Agents. 2016 Apr;47(4):269-85
pubmed: 27013000
Eur J Microbiol Immunol (Bp). 2015 Mar;5(1):44-61
pubmed: 25883793
Int J Antimicrob Agents. 2016 Aug;48(2):223-4
pubmed: 27378198
Microb Drug Resist. 2017 Dec;23(8):1013-1018
pubmed: 28375698
Infect Dis (Lond). 2015 Jan;47(1):46-51
pubmed: 25365029
Antimicrob Agents Chemother. 2015 Dec 14;60(3):1862-4
pubmed: 26666930
Eur J Clin Microbiol Infect Dis. 2018 Jan;37(1):175-183
pubmed: 29063446
Antimicrob Resist Infect Control. 2018 May 2;7:62
pubmed: 29744043
Int J Antimicrob Agents. 2019 Jun;53(6):864-867
pubmed: 30818000
Antibiotics (Basel). 2018 Dec 14;7(4):
pubmed: 30558235
Eur J Clin Microbiol Infect Dis. 2018 Dec;37(12):2241-2251
pubmed: 30171482
J Mol Biol. 1990 Oct 5;215(3):403-10
pubmed: 2231712
Antimicrob Resist Infect Control. 2019 Feb 22;8:44
pubmed: 30834112
Eur J Clin Microbiol Infect Dis. 2015 Oct;34(10):2069-74
pubmed: 26239064
Nat Microbiol. 2019 Nov;4(11):1919-1929
pubmed: 31358985
Scand J Infect Dis. 2014 Apr;46(4):320-4
pubmed: 24552581

Auteurs

Marius Surleac (M)

National Institute for Infectious Diseases 'Matei Bals', Bucharest, Romania.
Institute of Biochemistry, Romanian Academy, Bucharest, Romania.

Ilda Czobor Barbu (I)

The Research Institute of the University of Bucharest, Bucharest, Romania.

Simona Paraschiv (S)

National Institute for Infectious Diseases 'Matei Bals', Bucharest, Romania.

Laura Ioana Popa (LI)

The Research Institute of the University of Bucharest, Bucharest, Romania.
Department of Botany and Microbiology, Faculty of Biology, University of Bucharest, Bucharest, Romania.
The National Institute of Research and Development for Biological Sciences, Bucharest, Romania.

Irina Gheorghe (I)

The Research Institute of the University of Bucharest, Bucharest, Romania.
University of Medicine and Pharmacy "Carol Davila", Bucharest, Romania.

Luminita Marutescu (L)

The Research Institute of the University of Bucharest, Bucharest, Romania.
University of Medicine and Pharmacy "Carol Davila", Bucharest, Romania.

Marcela Popa (M)

The Research Institute of the University of Bucharest, Bucharest, Romania.

Ionela Sarbu (I)

The Research Institute of the University of Bucharest, Bucharest, Romania.
Department of Genetics, Faculty of Biology, University of Bucharest, Bucharest, Romania.

Daniela Talapan (D)

National Institute for Infectious Diseases 'Matei Bals', Bucharest, Romania.

Mihai Nita (M)

National Institute for R & D in Industrial Ecology (ECOIND), Bucharest, Romania.

Alina Viorica Iancu (AV)

Infectious Diseases Hospital Galati, Galati, Romania.
Faculty of Medicine and Pharmacy "Dunarea de Jos", University of Galati, Galati, Romania.

Manuela Arbune (M)

Infectious Diseases Hospital Galati, Galati, Romania.
Faculty of Medicine and Pharmacy "Dunarea de Jos", University of Galati, Galati, Romania.

Alina Manole (A)

Department of Botany and Microbiology, Faculty of Biology, University of Bucharest, Bucharest, Romania.

Serban Nicolescu (S)

Targoviste County Hospital, Targoviste, Romania.

Oana Sandulescu (O)

National Institute for Infectious Diseases 'Matei Bals', Bucharest, Romania.
University of Medicine and Pharmacy "Carol Davila", Bucharest, Romania.

Adrian Streinu-Cercel (A)

National Institute for Infectious Diseases 'Matei Bals', Bucharest, Romania.
University of Medicine and Pharmacy "Carol Davila", Bucharest, Romania.

Dan Otelea (D)

National Institute for Infectious Diseases 'Matei Bals', Bucharest, Romania.

Mariana Carmen Chifiriuc (MC)

The Research Institute of the University of Bucharest, Bucharest, Romania.
Department of Botany and Microbiology, Faculty of Biology, University of Bucharest, Bucharest, Romania.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH